Manuel Vilanova Selected Research

Manuel Vilanova Research Topics

Disease

15	Infections 06/2022 - 09/2005
7	Neoplasms (Cancer) 11/2020 - 08/2008
4	Candidiasis (Moniliasis) 01/2016 - 03/2004
3	Systemic candidiasis 01/2016 - 03/2004
2	Obesity 01/2018 - 01/2018
2	Parasitic Diseases (Parasitic Disease) 06/2015 - 02/2014
2	Necrosis 04/2015 - 12/2011
1	Colorectal Neoplasms (Colorectal Cancer) 11/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Congenital Toxoplasmosis 01/2020
1	Breast Neoplasms (Breast Cancer) 12/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Overweight 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Stomach Neoplasms (Stomach Cancer) 12/2016
1	Hyperplasia 07/2016
1	Hemolysis 04/2015
1	Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis) 01/2015
1	Persistent Infection 07/2014
1	Ulcerative Colitis 05/2014
1	Sepsis (Septicemia) 04/2014
1	Bacterial Infections (Bacterial Infection) 11/2011
1	Wounds and Injuries (Trauma) 07/2011
1	Neoplasm Metastasis (Metastasis) 11/2010
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2002

Drug/Important Bio-Agent (IBA)

4	Polysaccharides (Glycans)IBA 11/2020 - 10/2016
4	Virulence Factors (Pathogenicity Factors)IBA 07/2014 - 03/2004
3	CytokinesIBA 06/2022 - 01/2010
3	IronIBA 01/2022 - 01/2021
3	InterferonsIBA 01/2018 - 02/2014
3	AntibodiesIBA 02/2014 - 09/2005
2	Messenger RNA (mRNA)IBA 07/2020 - 09/2005
2	AdipokinesIBA 07/2020 - 06/2015
2	Leptin ReceptorsIBA 07/2020 - 01/2018
2	VaccinesIBA 01/2020 - 01/2020
2	EnzymesIBA 01/2020 - 11/2011
2	Interleukin-12 (IL 12)IBA 01/2018 - 01/2010
2	Galectin 3 (LGALS3)IBA 12/2016 - 11/2010
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2016 - 02/2014
2	Aspartic Acid ProteasesIBA 11/2010 - 03/2004
1	LeptinIBA 07/2020
1	Subunit VaccinesIBA 01/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	Pharmaceutical PreparationsIBA 12/2018
1	Drug CombinationsIBA 12/2018
1	LipidsIBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	SialyltransferasesIBA 12/2016
1	ptaquilosideIBA 11/2016
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 07/2016
1	Celecoxib (Celebrex)FDA Link 07/2016
1	monooleinIBA 01/2016
1	AntigensIBA 01/2016
1	Liposomes (Liposome)IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 06/2015
1	polyethylene glycol polyethyleneimine nanogelIBA 04/2015
1	5'-Nucleotidase (5' Nucleotidase)IBA 01/2015
1	Adenosine (Adenocard)FDA LinkGeneric 01/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2014
1	Immunoglobulin G (IgG)IBA 02/2014
1	Interleukin-1 (Interleukin 1)IBA 12/2011
1	Interleukin-6 (Interleukin 6)IBA 12/2011
1	Interleukin-10 (Interleukin 10)IBA 11/2011
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 11/2011
1	Dexamethasone (Maxidex)FDA LinkGeneric 07/2011
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2010
1	Interferon-gamma (Interferon, gamma)IBA 09/2005
1	Gemcitabine FDA Link 11/2002
1	Cisplatin (Platino)FDA LinkGeneric 11/2002

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 12/2016 - 08/2008
1	Immunotherapy 11/2020
1	Therapeutics 12/2018
1	Catheters 04/2014
1	Neoadjuvant Therapy 11/2002